Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.

about

Biological Effects of Space Radiation and Development of Effective Countermeasures.Potential interactions of prescription and over-the-counter medications having antioxidant capabilities with radiation and chemotherapy.

P2860

Q34220076-4113B9DA-F1CE-46AC-BDB2-97B2D90A112F Q34438605-358CD6B5-C572-43B2-8168-0BCA9885DEFB

P2860

Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.

Item

http://www.wikidata.org/entity/Q42130904

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Amifostine (WR2721) confers DN ...... e peripheral blood leukocytes.

@en

type

Item

label

Amifostine (WR2721) confers DN ...... e peripheral blood leukocytes.

@en

prefLabel

Amifostine (WR2721) confers DN ...... e peripheral blood leukocytes.

@en

P1476

Amifostine (WR2721) confers DN ...... e peripheral blood leukocytes.

@en

P2093

A G Fuchs

http://www.w3.org/2001/XMLSchema#string

E A Prieto González

http://www.w3.org/2001/XMLSchema#string

González S Sánchez

http://www.w3.org/2001/XMLSchema#string

P2860

Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations

Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing

A simple technique for quantitation of low levels of DNA damage in individual cells

Catalase in vitro

WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

Late toxicity following curative treatment of testicular cancer.

Amifostine: mechanisms of action underlying cytoprotection and chemoprevention.

Amifostine: chemotherapeutic and radiotherapeutic protective effects.

Amifostine in clinical oncology: current use and future applications.

P304

234-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2203/DOSE-RESPONSE.08-026.PRIETO

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19809542

http://www.w3.org/2001/XMLSchema#string

P932

2754537

http://www.w3.org/2001/XMLSchema#string

Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.

about

P2860

P2860

Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932